As of 5 Jul 2026, NEPHROCARE HEALTH SERV L share price is ₹671.95. The stock opened at ₹670.00, compared to its previous close of ₹674.95. During today's trading session, NEPHROCARE HEALTH SERV L share price moved in the range of ₹662.30 to ₹677.05, with an average price of ₹669.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹446.00 and a high of ₹769.75. On the performance front, NEPHROCARE HEALTH SERV L share price has increased by 41.64% over the last six months and is up 42.59% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹755.81 | ₹566.16 | ₹437.29 | ₹317.67 |
| Other Income | ₹14.10 | ₹8.57 | ₹5.96 | ₹9.53 |
| Total Revenue | ₹769.92 | ₹574.72 | ₹443.26 | ₹327.20 |
| Total Expenses | ₹682.48 | ₹541.56 | ₹451.85 | ₹354.34 |
| Profit Before Tax | ₹87.44 | ₹33.16 | -₹8.59 | -₹27.14 |
| Tax | ₹20.34 | -₹1.97 | ₹3.20 | -₹5.81 |
| Profit After Tax | ₹67.10 | ₹35.13 | -₹11.79 | -₹21.33 |
| EPS - Basic | ₹8.28 | ₹4.55 | -₹67.95 | -₹130.96 |
| EPS - Diluted | ₹8.01 | ₹4.40 | -₹67.95 | -₹130.96 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹87.44 | ₹33.16 | -₹8.59 | -₹27.14 |
| Income before WC changes | ₹180.48 | ₹113.35 | ₹59.97 | ₹37.41 |
| Change in Assets | -₹69.45 | -₹59.42 | -₹66.55 | -₹31.17 |
| Change in Liabilities | ₹25.28 | ₹26.42 | ₹13.23 | ₹12.89 |
| Change in WC | -₹44.17 | -₹33.00 | -₹53.32 | -₹18.28 |
| Cash flow from Operations | ₹135.35 | ₹72.28 | ₹11.27 | ₹14.35 |
| Cash flow from Investing | -₹125.07 | -₹50.66 | -₹78.21 | -₹129.30 |
| Cash flow from Financing | ₹54.37 | ₹26.74 | ₹59.97 | ₹121.29 |
| Total Cash Flow | ₹64.65 | ₹48.36 | -₹4.49 | ₹6.04 |
| Cash (Start of the year) | ₹61.15 | ₹14.06 | ₹18.55 | ₹12.52 |
| Cash (End of the year) | ₹125.82 | ₹61.15 | ₹14.06 | ₹18.55 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹451.10 | ₹415.98 | ₹341.98 | ₹286.07 |
| Current Assets | ₹545.36 | ₹390.03 | ₹324.25 | ₹284.57 |
| Total Assets | ₹996.46 | ₹806.02 | ₹666.23 | ₹570.64 |
| Current Liabilities | ₹283.90 | ₹242.59 | ₹174.61 | ₹93.77 |
| Net Current Asset | ₹261.46 | ₹147.45 | ₹149.64 | ₹190.81 |
| Non-Current Liabilities | ₹128.45 | ₹149.72 | ₹102.99 | ₹80.88 |
| Equity Capital | ₹584.11 | ₹413.71 | ₹388.63 | ₹396.00 |
| Total Equity & Liabilities | ₹996.46 | ₹806.02 | ₹666.23 | ₹570.64 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹543.60 | ₹436.23 | ₹386.11 | ₹316.90 |
| Other Income | ₹15.63 | ₹7.80 | ₹5.09 | ₹3.56 |
| Total Revenue | ₹559.23 | ₹444.03 | ₹391.20 | ₹320.46 |
| Total Expenses | ₹513.87 | ₹443.82 | ₹404.08 | ₹348.53 |
| Profit Before Tax | ₹45.36 | ₹0.22 | -₹12.88 | -₹28.07 |
| Tax | ₹11.12 | -₹3.67 | ₹2.59 | -₹6.10 |
| Profit After Tax | ₹34.24 | ₹3.88 | -₹15.47 | -₹21.98 |
| EPS - Basic | ₹4.23 | ₹0.50 | -₹29.86 | -₹132.53 |
| EPS - Diluted | ₹4.23 | ₹0.50 | -₹29.86 | -₹132.53 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹45.36 | ₹0.22 | -₹12.88 | -₹28.07 |
| Income before WC changes | ₹104.27 | ₹60.81 | ₹44.57 | ₹33.18 |
| Change in Assets | -₹52.40 | -₹21.96 | -₹45.57 | -₹26.62 |
| Change in Liabilities | ₹22.47 | ₹20.30 | ₹8.19 | ₹10.15 |
| Change in WC | -₹29.92 | -₹1.66 | -₹37.38 | -₹16.47 |
| Cash flow from Operations | ₹79.73 | ₹53.34 | ₹11.14 | ₹11.92 |
| Cash flow from Investing | -₹103.52 | -₹19.26 | -₹74.71 | -₹167.49 |
| Cash flow from Financing | ₹26.02 | -₹35.54 | ₹63.39 | ₹147.37 |
| Total Cash Flow | ₹2.23 | -₹1.46 | -₹0.18 | -₹8.20 |
| Cash (Start of the year) | ₹1.62 | ₹3.08 | ₹3.26 | ₹11.45 |
| Cash (End of the year) | ₹3.85 | ₹1.62 | ₹3.08 | ₹3.26 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹425.36 | ₹408.02 | ₹364.30 | ₹316.95 |
| Current Assets | ₹331.25 | ₹256.55 | ₹282.59 | ₹254.96 |
| Total Assets | ₹756.61 | ₹664.57 | ₹646.89 | ₹571.91 |
| Current Liabilities | ₹154.90 | ₹185.03 | ₹156.85 | ₹84.78 |
| Net Current Asset | ₹176.36 | ₹71.53 | ₹125.73 | ₹170.17 |
| Non-Current Liabilities | ₹59.71 | ₹75.33 | ₹93.39 | ₹75.13 |
| Equity Capital | ₹542.01 | ₹404.22 | ₹396.65 | ₹411.99 |
| Total Equity & Liabilities | ₹756.61 | ₹664.57 | ₹646.89 | ₹571.91 |
Nephrocare Health Services Limited, formerly Nephrocare Health Services Pvt Ltd, is an India-based company. The Company is primarily engaged in the business of providing dialysis and sale of related healthcare services and products. The Company offers comprehensive dialysis care through the network of clinics from diagnosis to treatment and wellness programs including hemodialysis, home and mobile dialysis, supported by a pharmacy. It has a network of approximately 490 clinics, with 43 clinics internationally across the Philippines, Uzbekistan and Nepal. Its subsidiaries include Nephrocare Health Services Central Asia FE LLC, Nephrocare Health Services International Pte. Ltd, Nephrocare Health Services Nepal Private Limited, and others.
NEPHROCARE HEALTH SERV L share price is ₹671.95 as on 03 Jul, 2026, 15:57 IST.
In the last 1 year, NEPHROCARE HEALTH SERV L delivered a return of 42.59%. The NEPHROCARE HEALTH SERV L share price hit a high of ₹769.75 and low of ₹446.00.
The Mutual Fund Shareholding in NEPHROCARE HEALTH SERV L was 3.17% at the end of Mar 2026.
The 52-week high and low of NEPHROCARE HEALTH SERV L share is ₹769.75 and ₹446.00 as of 03 Jul, 2026.
The market capitalisation of NEPHROCARE HEALTH SERV L is ₹6,764.47 Crores as on 03 Jul, 2026.
The stock symbol of NEPHROCARE HEALTH SERV L is NEPHROPLUS on the NSE, 544647 on the BSE, and the ISIN is INE428V01029.
NEPHROCARE HEALTH SERV L shares closed yesterday at ₹674.95 on NSE & ₹674.15 on BSE
To buy NEPHROCARE HEALTH SERV L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of NEPHROCARE HEALTH SERV L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell NEPHROCARE HEALTH SERV L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of NEPHROCARE HEALTH SERV L is 88.01 and 6.06 respectively, as on 03 Jul, 2026, 15:57 IST.